Another iPS product approved for public insurance coverage in Japan
The Central Social Insurance Medical Council, which advises the health minister, on Wednesday approved the application of public…
Long-term safety of iPS spinal cord therapy confirmed in Japan
Long-term safety has been confirmed after neural progenitor cells derived from induced pluripotent stem cells, or iPS cells,…
Japan startup tests catheter injection of iPS heart muscle cells
Japanese startup Heartseed has said it conducted a clinical trial to inject via catheter small masses of heart…
Can iPS Cell Therapies Enter Mainstream Medicine?
Two regenerative medicine products made with induced pluripotent stem cells (iPS cells) have received conditional, time-limited approval for…